XSNX NovAccess Global Inc (QB)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Martin Daniel G.	2. Issuer Name and Ticker or Trading Symbol NovAccess Global Inc. [ XSNX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    __X__ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chief Executive Officer
(Last)          (First)          (Middle) 8834 MAYFIELD RD	3. Date of Earliest Transaction (MM/DD/YYYY) 9/4/2020
(Street) CHESTERLAND, OH 44026 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series A Preferred Stock, $0.01 par value per share	9/4/2020		J(1)		5000	D	$0	0	I	By TN3, LLC
Series B Preferred Stock, $0.01 par value per share	9/4/2020		J(1)		25000	A	$0	25000	I	By TN3, LLC
Common Stock, no par value	9/8/2020		J(2)		7500000	A	$0	7500000	I	By Innovest Global, Inc.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Preferred Stock, $0.01 par value	$0	9/8/2020		J (2)		25000		9/8/2020	(3)	Common Stock, no par value	250000000	$0	25000	I	By TN3, LLC

Explanation of Responses:
(1)	On September 4, 2020, NovAccess Global Inc. (the "Company") redeemed 5,000 shares of Series A preferred stock held by TN3, LLC ("TN3") for 25,000 shares of the Company's Series B preferred stock. The holder of the Company's shares of Series A preferred is entitled to cast a number of votes equal to that number of common shares of the Company which is not less than 60% of the vote required to approve an action on all matters voted on the Company's shareholders. Each share of Series B preferred in convertible by the holder into 10,000 shares of the Company's common stock and entitles the holder to cast 40,000 votes on all matters voted on by the Company's shareholders.
(2)	On September 8, 2020, the Company issued 7,500,000 shares of common stock to Innovest Global, Inc. ("Innovest") for all of the outstanding interests of StemVax, LLC. Mr. Martin is the chairman and a significant shareholder of Innovest. Mr. Martin disclaims beneficial ownership of the shares of the Company's common stock held by Innovest.
(3)	None.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Martin Daniel G. 8834 MAYFIELD RD CHESTERLAND, OH 44026	X	X	Chief Executive Officer

Signatures
/s/ Daniel G. Martin		9/9/2020
**Signature of Reporting Person		Date